These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 3921386)
21. Anti-inflammatory drugs, prostanoid and proteoglycan production by cultured bovine articular chondrocytes. Mitrovic D; McCall E; Front P; Aprile F; Darmon N; Dray F Prostaglandins; 1984 Sep; 28(3):417-34. PubMed ID: 6595718 [TBL] [Abstract][Full Text] [Related]
22. Prostanoid synthesis in whole blood cells from fish of the Arabian Gulf. Thomson M; al-Hassan JM; al-Saleh J; Fayad S; Ali M Comp Biochem Physiol B Biochem Mol Biol; 1998 Apr; 119(4):639-46. PubMed ID: 9787758 [TBL] [Abstract][Full Text] [Related]
23. The relation between thromboxane and prostaglandin synthesis in human decidua tissue: a comparison of eicosanoid synthesis in minced tissue with that in a cell-free preparation. Asbóth G; Gimes G; Hertelendy F; Tóth M Biochim Biophys Acta; 1989 Mar; 1002(1):101-8. PubMed ID: 2493805 [TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects of copper-aspirin complex on platelet aggregation. Shen ZQ; Chen ZH; Ma GY; Wang DC; Wu WL; Liu WP; Yang YK; Xiong HZ Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):358-62. PubMed ID: 10072923 [TBL] [Abstract][Full Text] [Related]
25. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation. Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196 [TBL] [Abstract][Full Text] [Related]
26. Single intravenous and oral doses of fenflumizole: pharmacokinetics and effects on prostanoid formation. Vinge E; Arnold E; Rasmussen SN; Midskov C Acta Pharmacol Toxicol (Copenh); 1985 Aug; 57(2):121-9. PubMed ID: 3840639 [TBL] [Abstract][Full Text] [Related]
27. Effect of exogenous arachidonic acid and enzyme inhibitors on placental prostanoid production. Kang IS; Siler-Khodr TM Placenta; 1993; 14(3):341-53. PubMed ID: 8367414 [TBL] [Abstract][Full Text] [Related]
28. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets. Patscheke H; Stegmeier K Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261 [TBL] [Abstract][Full Text] [Related]
29. "In vitro" and "ex vivo" effects of picotamide, a combined thromboxane A2-synthase inhibitor and -receptor antagonist, on human platelets. Berrettini M; De Cunto M; Parise P; Grasselli S; Nenci GG Eur J Clin Pharmacol; 1990; 39(5):495-500. PubMed ID: 1963845 [TBL] [Abstract][Full Text] [Related]
30. Effect of pirazolac on prostanoid synthesis by human gastric mucosa in vitro. Tavares IA; Bennett A Drugs Exp Clin Res; 1990; 16(1):1-6. PubMed ID: 2115830 [TBL] [Abstract][Full Text] [Related]
31. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions. Lagarde M; Felisi O; Boukhchache D; Sicard B; Dechavanne M Thromb Res; 1984 Jul; 35(2):141-7. PubMed ID: 6089369 [TBL] [Abstract][Full Text] [Related]
32. Involvement of arachidonic acid metabolites in acute inflammation: detection of 6-keto-PGF1 alpha, thromboxane B2 and PGD2 in rat pleurisy induced by phorbol myristate acetate. Kiyomiya K; Oh-ishi S Jpn J Pharmacol; 1985 Oct; 39(2):201-6. PubMed ID: 3936958 [TBL] [Abstract][Full Text] [Related]
33. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine. Stuart MJ; Dusse J; Clark DA; Walenga RW Pediatr Res; 1984 Sep; 18(9):823-6. PubMed ID: 6435080 [TBL] [Abstract][Full Text] [Related]
34. Effects of arachidonic acid and prostaglandin F2 alpha in isolated rat lungs. Ruttner E; Huszár E; Barát E; Debreczeni LA Acta Physiol Hung; 1990; 75(1):53-60. PubMed ID: 2111075 [TBL] [Abstract][Full Text] [Related]
35. PGE2, PGF2 alpha, 6-keto-PGF1 alpha, and TxB2 synthesis along the rabbit nephron. Farman N; Pradelles P; Bonvalet JP Am J Physiol; 1987 Jan; 252(1 Pt 2):F53-9. PubMed ID: 3101513 [TBL] [Abstract][Full Text] [Related]
36. Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour. Parry MJ Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):23S-29S. PubMed ID: 6401997 [TBL] [Abstract][Full Text] [Related]
37. Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor. Chiabrando C; Broggini M; Castelli MG; Cozzi E; Castagnoli MN; Donelli MG; Garattini S; Giavazzi R; Fanelli R Cancer Res; 1987 Feb; 47(4):988-91. PubMed ID: 3100032 [TBL] [Abstract][Full Text] [Related]
38. Effects of Y-20811, a long-lasting thromboxane synthetase inhibitor, on thromboxane production and platelet function. Mikashima H; Ochi H; Muramoto Y; Yasuda H; Tsuruta M; Maruyama Y Thromb Res; 1986 Aug; 43(4):455-68. PubMed ID: 3094191 [TBL] [Abstract][Full Text] [Related]
39. Thromboxane B2, 6-keto-prostaglandin F1 alpha, and prostaglandin F2 alpha production by contracting pregnant rate uteri in vitro. Dubin NH; Blake DA; Ghodgaonkar RB; Egner PG Biol Reprod; 1982 Mar; 26(2):281-8. PubMed ID: 6950795 [TBL] [Abstract][Full Text] [Related]
40. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease. Uyama O; Nagatsuka K; Nakabayashi S; Isaka Y; Yoneda S; Kimura K; Abe H Stroke; 1985; 16(2):241-4. PubMed ID: 3883580 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]